Optics
← Today's headlines

3 sources checked · 2 source groups included · 1h ago

Still Watching

An m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

Scientific American and WYFF4 (Hearst, Greenville) describe the same event in different terms.

2 Left1 Center0 Right
Still watching. Optics is waiting for a cleaner match before calling the split.

STILL WATCHING

As of October 22, 2026 at 11:54 PM, this is how Optics News reads the wording differences in this story.

What happened A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.
The headline split The left frames it as "A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%". The center frames it as "An m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning".
Match confidence Medium confidence. 3 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium

3 sources across 2 bias buckets agree on the event.

Framing confidenceModerate

65/99 — meaningful wording shift across the spectrum.

WHAT EACH SIDE EMPHASIZED

Left / center-leftA Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

Time · Center-left · News report

CenterAn m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

WDSU New Orleans (Hearst) · Center · News report

Right / center-rightNo matching source in this bucket yet.

Optics keeps watching for pickup.

SEE THE HEADLINES

CenterHigh
WDSU New Orleans (Hearst)News report · Oct 22, 11:22 PM

An m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.

Open source
Center-leftHigh
TimeNews report · Oct 22, 11:54 PM

A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.

Open source
Center-leftHigh
Scientific AmericanNews report · Oct 22, 10:55 PM

Here’s what Moderna’s latest m RNA cancer vaccine data actually show

The Moderna-Merck m RNA cancer vaccine helps prevent cancer recurrence and death, the new results show

Open source
Details65/99 Wording Gap · Medium confidence · 3 sources
65/99 Wording GapMedium confidence3 sources · 2 bias bucketsLive match · 12 sources · 2 buckets · comparable news formatFormats: News report

SOURCE MAP CHANGES

Oct 22, 10:55 PM: Scientific American joined the source map.

Oct 22, 11:22 PM: WDSU New Orleans (Hearst) joined the source map.

Oct 22, 11:54 PM: Time joined the source map.

Now: Wording Gap is 65/99 and story health is live match · 12 sources · 2 buckets · comparable news format.